p.109 抽出テキスト
nonischemic cardiomyopathy treatment evaluation study. Arch Intern Med 2007;167: 2226–2232. https://doi.org/10.1001/archinte.167.20.2226 562. Ni SQ, Ni J, Yang N, Wang J. Effect of magnetic nanoparticles on the performance of activated sludge treatment system. Bioresour Technol 2013;143:555–561. https://doi. org/10.1016/j.biortech.2013.06.041 563. von Kanel R, Baumert J, Kolb C, Cho E-Y, Ladwig K-H. Chronic posttraumatic stress and its predictors in patients living with an implantable cardioverter defibrillator. J Affect Disord 2011;131:344–352. https://doi.org/10.1016/j.jad.2010.12.002 564. Lewis KB, Carroll SL, Birnie D, Stacey D, Matlock DD. Incorporating patients’ preference diagnosis in implantable cardioverter defibrillator decision-making: a review of recent literature. Curr Opin Cardiol 2018;33:42–49. https://doi.org/10.1097/HCO. 0000000000000464 565. Luiten RC, Ormond K, Post L, Asif IM, Wheeler MT, Caleshu C. Exercise restrictions trigger psychological difficulty in active and athletic adults with hypertrophic cardiomyopathy. Open Heart 2016;3:e000488. https://doi.org/10.1136/openhrt-2016-000488 566. Subas T, Luiten R, Hanson-Kahn A, Wheeler M, Caleshu C. Evolving decisions: perspectives of active and athletic individuals with inherited heart disease who exercise against recommendations. J Genet Couns 2019;28:119–129. https://doi.org/10.1007/ s10897-018-0297-6 567. Alpert C, Day SM, Saberi S. Sports and exercise in athletes with hypertrophic cardiomyopathy. Clin Sports Med 2015;34:489–505. https://doi.org/10.1016/j.csm.2015.03. 005 568. Day SM. Exercise in hypertrophic cardiomyopathy. J Cardiovasc Transl Res 2009;2: 407–414. https://doi.org/10.1007/s12265-009-9134-5 569. Simon NM. Treating complicated grief. JAMA 2013;310:416–423. https://doi.org/10. 1001/jama.2013.8614 570. McDonald K, Sharpe L, Yeates L, Semsarian C, Ingles J. Needs analysis of parents following sudden cardiac death in the young. Open Heart 2020;7:e001120. https://doi.org/ 10.1136/openhrt-2019-001120 571. Wisten A, Zingmark K. Supportive needs of parents confronted with sudden cardiac death–a qualitative study. Resuscitation 2007;74:68–74. https://doi.org/10.1016/j. resuscitation.2006.11.014 572. O’Donovan CE, Waddell-Smith KE, Skinner JR, Broadbent E. Predictors of β-blocker adherence in cardiac inherited disease. Open Heart 2018;5:e000877. https://doi.org/10. 1136/openhrt-2018-000877 573. Cupples S, Dew MA, Grady KL, De Geest S, Dobbels F, Lanuza D, et al. Report of the Psychosocial Outcomes Workgroup of the Nursing and Social Sciences Council of the International Society for Heart and Lung Transplantation: present status of research on psychosocial outcomes in cardiothoracic transplantation: review and recommendations for the field. J Heart Lung Transplant 2006;25:716–725. https://doi.org/10.1016/j. healun.2006.02.005 574. Aatre RD, Day SM. Psychological issues in genetic testing for inherited cardiovascular diseases. Circ Cardiovasc Genet 2011;4:81–90. https://doi.org/10.1161/ CIRCGENETICS.110.957365 575. Burns C, James C, Ingles J. Communication of genetic information to families with inherited rhythm disorders. Heart Rhythm 2018;15:780–786. https://doi.org/10.1016/j. hrthm.2017.11.024 576. Yeates L, Hunt L, Saleh M, Semsarian C, Ingles J. Poor psychological wellbeing particularly in mothers following sudden cardiac death in the young. Eur J Cardiovasc Nurs 2013;12:484–491. https://doi.org/10.1177/1474515113485510 577. Karam N, Jabre P, Narayanan K, Sharifzadehgan A, Perier MC, Tennenbaum J, et al. Psychological support and medical screening of first-degree relatives of sudden cardiac arrest victims. JACC Clin Electrophysiol 2020;6:586–587. https://doi.org/10.1016/j.jacep. 2020.02.002 578. Kampmann C, Wiethoff CM, Wenzel A, Stolz G, Betancor M, Wippermann CF, et al. Normal values of M mode echocardiographic measurements of more than 2000 healthy infants and children in central Europe. Heart 2000;83:667–672. https://doi. org/10.1136/heart.83.6.667 579. Cardim N, Galderisi M, Edvardsen T, Plein S, Popescu BA, D’Andrea A, et al. Role of multimodality cardiac imaging in the management of patients with hypertrophic cardiomyopathy: an expert consensus of the European Association of Cardiovascular Imaging Endorsed by the Saudi Heart Association. Eur Heart J Cardiovasc Imaging 2015;16:280. https://doi.org/10.1093/ehjci/jeu291 580. Maron MS, Finley JJ, Bos JM, Hauser TH, Manning WJ, Haas TS, et al. Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy. Circulation 2008;118:1541–1549. https://doi.org/10.1161/ CIRCULATIONAHA.108.781401 581. Weinsaft JW, Kim HW, Crowley AL, Klem I, Shenoy C, Van Assche L, et al. LV thrombus detection by routine echocardiography: insights into performance characteristics using delayed enhancement CMR. JACC Cardiovasc Imaging 2011;4:702–712. https://doi. org/10.1016/j.jcmg.2011.03.017 582. Brouwer WP, Germans T, Head MC, van der Velden J, Heymans MW, Christiaans I, et al. Multiple myocardial crypts on modified long-axis view are a specific finding in prehypertrophic HCM mutation carriers. Eur Heart J Cardiovasc Imaging 2012;13: 292–297. https://doi.org/10.1093/ehjci/jes005 583. Maron MS, Rowin EJ, Lin D, Appelbaum E, Chan RH, Gibson CM, et al. Prevalence and clinical profile of myocardial crypts in hypertrophic cardiomyopathy. Circ Cardiovasc Imaging 2012;5:441–447. https://doi.org/10.1161/CIRCIMAGING.112.972760 584. Spirito P, Autore C, Rapezzi C, Bernabo P, Badagliacca R, Maron MS, et al. Syncope and risk of sudden death in hypertrophic cardiomyopathy. Circulation 2009;119: 1703–1710. https://doi.org/10.1161/CIRCULATIONAHA.108.798314 585. Vogelsberg H, Mahrholdt H, Deluigi CC, Yilmaz A, Kispert EM, Greulich S, et al. Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy. J Am Coll Cardiol 2008;51: 1022–1030. https://doi.org/10.1016/j.jacc.2007.10.049 586. Syed IS, Glockner JF, Feng D, Araoz PA, Martinez MW, Edwards WD, et al. Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis. JACC Cardiovasc Imaging 2010;3:155–164. https://doi.org/10.1016/j.jcmg.2009.09.023 587. Wigle ED, Sasson Z, Henderson MA, Ruddy TD, Fulop J, Rakowski H, et al. Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review. Prog Cardiovasc Dis 1985;28:1–83. https://doi.org/10.1016/0033- 0620(85)90024-6 588. Dimitrow PP, Bober M, Michalowska J, Sorysz D. Left ventricular outflow tract gradient provoked by upright position or exercise in treated patients with hypertrophic cardiomyopathy without obstruction at rest. Echocardiography 2009;26:513–520. https://doi.org/10.1111/j.1540-8175.2008.00851.x 589. Maron BJ, Gottdiener JS, Bonow RO, Epstein SE. Hypertrophic cardiomyopathy with unusual locations of left ventricular hypertrophy undetectable by M-mode echocardiography. Identification by wide-angle two-dimensional echocardiography. Circulation 1981;63:409–418. https://doi.org/10.1161/01.CIR.63.2.409 590. Elliott P, Gimeno J, Tome M, McKenna W. Left ventricular outflow tract obstruction and sudden death in hypertrophic cardiomyopathy. Eur Heart J 2006;27:3073; author reply 3073-4. https://doi.org/10.1093/eurheartj/ehl383 591. Wigle ED, Rakowski H, Kimball BP, Williams WG. Hypertrophic cardiomyopathy. Clinical spectrum and treatment. Circulation 1995;92:1680–1692. https://doi.org/10. 1161/01.CIR.92.7.1680 592. Spirito P, Bellone P, Harris KM, Bernabo P, Bruzzi P, Maron BJ. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med 2000;342:1778–1785. https://doi.org/10.1056/NEJM200006153422403 593. Elliott PM, Gimeno Blanes JR, Mahon NG, Poloniecki JD, McKenna WJ. Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy. Lancet 2001;357:420–424. https://doi.org/10.1016/S0140- 6736(00)04005-8 594. Kumar S, Van Ness G, Bender A, Yadava M, Minnier J, Ravi S, et al. Standardized goaldirected valsalva maneuver for assessment of inducible left ventricular outflow tract obstruction in hypertrophic cardiomyopathy. J Am Soc Echocardiogr 2018;31: 791–798. https://doi.org/10.1016/j.echo.2018.01.022 595. Maron MS, Olivotto I, Zenovich AG, Link MS, Pandian NG, Kuvin JT, et al. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation 2006;114:2232–2239. https://doi.org/10.1161/ CIRCULATIONAHA.106.644682 596. Shah JS, Esteban MT, Thaman R, Sharma R, Mist B, Pantazis A, et al. Prevalence of exercise-induced left ventricular outflow tract obstruction in symptomatic patients with non-obstructive hypertrophic cardiomyopathy. Heart 2008;94:1288–1294. https://doi.org/10.1136/hrt.2007.126003 597. Marwick TH, Nakatani S, Haluska B, Thomas JD, Lever HM. Provocation of latent left ventricular outflow tract gradients with amyl nitrite and exercise in hypertrophic cardiomyopathy. Am J Cardiol 1995;75:805–809. https://doi.org/10.1016/S0002-9149(99) 80416-0 598. Reant P, Dufour M, Peyrou J, Reynaud A, Rooryck C, Dijos M, et al. Upright treadmill vs. semi-supine bicycle exercise echocardiography to provoke obstruction in symptomatic hypertrophic cardiomyopathy: a pilot study. Eur Heart J Cardiovasc Imaging 2018;19:31–38. https://doi.org/10.1093/ehjci/jew313 599. Yu EH, Omran AS, Wigle ED, Williams WG, Siu SC, Rakowski H. Mitral regurgitation in hypertrophic obstructive cardiomyopathy: relationship to obstruction and relief with myectomy. J Am Coll Cardiol 2000;36:2219–2225. https://doi.org/10.1016/ S0735-1097(00)01019-6 600. Oki T, Fukuda N, Iuchi A, Tabata T, Tanimoto M, Manabe K, et al. Transesophageal echocardiographic evaluation of mitral regurgitation in hypertrophic cardiomyopathy: contributions of eccentric left ventricular hypertrophy and related abnormalities of the mitral complex. J Am Soc Echocardiogr 1995;8:503–510. https://doi.org/10.1016/S0894- 7317(05)80338-4 601. Grigg LE, Wigle ED, Williams WG, Daniel LB, Rakowski H. Transesophageal Doppler echocardiography in obstructive hypertrophic cardiomyopathy: clarification of pathophysiology and importance in intraoperative decision making. J Am Coll Cardiol 1992;20: 42–52. https://doi.org/10.1016/0735-1097(92)90135-A 602. Marwick TH, Stewart WJ, Lever HM, Lytle BW, Rosenkranz ER, Duffy CI, et al. Benefits of intraoperative echocardiography in the surgical management of hypertrophic cardiomyopathy. J Am Coll Cardiol 1992;20:1066–1072. https://doi.org/10.1016/0735- 1097(92)90359-U ESC Guidelines 3611 Downloaded from academic.oup.com/eurheartj/article/44/37/3503/7246608 by guest on 07 October 2026